Research and Development

Amgen is to pay $290 million to buy Avidia, a Californian biotech company which is developing innovative new protein-based medicines.Based …

A new treatment for multiple sclerosis currently being developed by Novartis has shown further promise in slowing the progress of …

AstraZeneca has officially opened two major research laboratories in the UK, which it says demonstrates its commitment to R&D in …

AstraZeneca and Schering are to co-develop a promising new drug candidate to treat breast cancer, with the two partners taking …

NicOx is to develop a new statin treatment using its special in-house technology which, according to the company, could make …

Santhera Pharmaceuticals is collaborating with Finnish biotech company Juvantia Pharma to develop a treatment for dyskinesia, the distressing involuntary movements …

AstraZeneca is to work with a spin-off company set up by Cancer Research UK to research and develop new treatments …

 Over the years, the numbers of women taking up positions of authority in the pharmaceutical industry has grown considerably, and …

Here's a challenge: find someone with PhD-level scientific knowledge, a strong management track record and entrepreneurial flair. If there are …

GlaxoSmithKline has formed an alliance with Californian biotech company ChemoCentryx through its innovative drug development partnering unit.A licensing deal has …

The blockbuster non-Hodgkin's lymphoma treatment MabThera could offer a new treatment option for people with multiple sclerosis according to new …

Recently I was wandering through the local market, and found myself in front of a stall selling therapeutic magnets. I …

Pfizer's new chief executive Jeffery Kindler has unveiled changes to the company's senior management structure just days into his new …

The announcements on NHS budget deficits and the debates surrounding the prescribing of costly drugs, such as in the  Herceptin …

UK biotech company Vernalis has started enrolment into a phase II trial of V3381, a drug designed for patients with …